share_log

ADC Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-AstraZeneca PLC(4.88%),AstraZeneca UK Limited(4.88%)

SEC announcement ·  Feb 12 10:14
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more